載入中
NASDAQHealthcareMedical - Diagnostics & Research
最新資料
US$67.715
−US$0.895 · -1.30%
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
一般交易時段
US$67.715
−US$0.895 · -1.30%
盤中時間採用ET。市場資料可能有所延遲。
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
日內區間
目前US$67.715
52週區間
目前US$67.715
盤中時間採用ET。市場資料可能有所延遲。
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
日內區間
目前US$67.715
52週區間
目前US$67.715
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 20.4億 USD | 18.3億 USD | 16.17億 USD | 14.3億 USD | 13.15億 USD |
| 銷貨成本 | 19.49億 USD | 15.81億 USD | 13.95億 USD | 12.64億 USD | 11.23億 USD |
| 毛利 | 9080.4萬 USD | 2.49億 USD | 2.21億 USD | 1.66億 USD | 1.92億 USD |
| 營業費用 | — | 1.44億 USD | 1.23億 USD | 1.19億 USD | 1.09億 USD |
| 利息支出 | 6991.3萬 USD | 7984.9萬 USD | 6448.3萬 USD | 5084.1萬 USD | 4883萬 USD |
| 折舊和攤銷 | 1.52億 USD | 1.38億 USD | 1.89億 USD | 1.85億 USD | 1.71億 USD |
| 營業利益 | 9080.4萬 USD | 1.05億 USD | 9869.7萬 USD | 4636.3萬 USD | 8255.4萬 USD |
| 淨利 | −1865.2萬 USD | 279.3萬 USD | 304.4萬 USD | 1065萬 USD | 2472.7萬 USD |
公司資料更新於 2026年10月8日。
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR2.41億0.23%1042.94億 USD0.06%US$136.97-0.08%
Vanguard Morningstar Total Stock Market ETFVTI1.71億0.01%2.3兆 USD0.03%US$378.34-0.71%
iShares Russell 2000 ETFIWM1.29億0.16%785.63億 USD0.19%US$277.04-0.24%
Vanguard Morningstar Small-Cap ETFVB1.23億0.07%1853億 USD0.03%US$286.51-0.17%
Defiance Quantum ETFQTUM7775.48萬1.33%59.15億 USD0.40%US$149.86-2.97%
Vanguard Morningstar Small-Cap Growth ETFVBK7090.38萬0.16%447億 USD0.05%US$338.67-1.04%
Vanguard Extended Market ETFVXF6237.42萬0.06%954億 USD0.05%US$232.27-0.52%
iShares Russell 2000 Growth ETFIWO4593.35萬0.33%142.49億 USD0.24%US$352.29-0.87%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBDefiance Quantum ETFQTUMVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
